Home LiteratureArticle Details
PMID: 404387 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth.

The Journal of experimental medicine ·Vol. 145 ·No. 5 ·1977-05-01 ·Pages 1264-77

Spitalny GL, North RJ

Abstract

Mice carrying any one of three murine tumors in their right hind foot pad were incapable of eliminating an inoculum of the bacterial parasite Listeria monocytogenes from the progressive tumor. In contrast, they were as capable as control mice in efficiently eliminating the organism from their contralateral tumor-free foot pad, and from their lymph nodes and livers. The results serve to show, therefore, that conditions within an established tumor are not only antagonistic to the expression of concomitant anti-tumor immunity, but that they are also antagonistic to the expression of T-cell-mediated anti-bacterial immunity. The possibility was discussed that the tumor contains factors that act pharmacologically to locally suppress the function of sensitized T cells and activated macrophages.

MeSH Terms
Animals Immunosuppression Therapy Listeria monocytogenes/isolation & purification Listeriosis/immunology Mice Mice, Inbred A Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred DBA Neoplasms, Experimental/immunology,microbiology T-Lymphocytes/immunology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Spitalny G L
North R J
References (23)
23 references, click to expand
  1. The inflammatory response to a foreign body within transplantable tumors.
    Cancer Res. 1962 Apr;22:334-8 PMID: 14468462
  2. ABNORMAL CELLULAR RESPONSE TO SKIN ABRASION IN CANCER PATIENTS.
    Cancer. 1963 Oct;16:1288-92 PMID: 14074212
  3. The reticuloendothelial system and the neoplastic process.
    Ann N Y Acad Sci. 1960 Jun 21;88:264-80 PMID: 13730686
  4. Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.
    J Immunol. 1976 Oct;117(4):1243-9 PMID: 185294
  5. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.
    J Exp Med. 1977 Feb 1;145(2):275-92 PMID: 401860
  6. Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance.
    Nat New Biol. 1972 Jan 12;235(54):48-50 PMID: 4109405
  7. Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes.
    Nat New Biol. 1972 Aug 9;238(84):185-6 PMID: 4340574
  8. Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis.
    J Natl Cancer Inst. 1972 Jul;49(1):119-30 PMID: 4338767
  9. Impaired inflammatory response in tumor-bearing guinea pigs.
    J Natl Cancer Inst. 1972 Dec;49(6):1641-7 PMID: 4346018
  10. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages.
    J Exp Med. 1973 Sep 1;138(3):625-44 PMID: 4353819
  11. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.
    Proc R Soc Med. 1973 May;66(5):466-8 PMID: 4351926
  12. Antiinflammatory effects of murine malignant cells.
    Proc Natl Acad Sci U S A. 1974 Oct;71(10):4052-6 PMID: 4215075
  13. Nonspecific suppression of tumor growth by an immune reaction to Listeria monocytogenes.
    J Natl Cancer Inst. 1974 Jan;52(1):193-8 PMID: 4204245
  14. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation.
    J Immunol. 1976 Mar;116(3):585-9 PMID: 176265
  15. Brief communication: quantitative impairment of primary inflammatory response in patients with cancer.
    J Natl Cancer Inst. 1973 Sep;51(3):1075-6 PMID: 4743556
  16. Cellular immunity against tumor antigens.
    Adv Cancer Res. 1969;12:167-223 PMID: 4898911
  17. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Int J Cancer. 1975 Mar 15;15(3):438-50 PMID: 1079792
  18. Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity.
    J Exp Med. 1976 Mar 1;143(3):574-84 PMID: 1249521
  19. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection.
    J Exp Med. 1976 Mar 1;143(3):559-73 PMID: 1249520
  20. Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.
    Cancer Res. 1971 Nov;31(11):1655-62 PMID: 5121668
  21. Enhanced growth of primary Moloney virus-induced sarcomas in mice.
    Int J Cancer. 1971 Jul 15;8(1):22-31 PMID: 5118209
  22. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Int J Cancer. 1971 Mar 15;7(2):226-37 PMID: 5104167
  23. On concomitant immunity in tumour-bearing hamsters.
    Nature. 1967 Feb 18;213(5077):674-6 PMID: 6031772
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1977-05-01
Pages
1264-77
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2180651
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]